Hairong Zhou

机构：Nanjing Municipal Center for Disease Control And Prevention · ORCID：0000-0002-6892-7254

发表论文 62 篇 · 总被引 624 次 · h-index 15

代表论文

• Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors (2021 · Diabetes and Vascular Disease Research · 被引 108)
• Association of socioeconomic status with hypertension prevalence and control in Nanjing: a cross-sectional study (2022 · BMC Public Health · 被引 47)
• Comparison of novel and traditional anthropometric indices in Eastern-China adults: which is the best indicator of the metabolically obese normal weight phenotype? (2024 · BMC Public Health · 被引 31)
• Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study (2023 · Open Life Sciences · 被引 22)
• Effects of SGLT2 inhibitors on cardiovascular and renal outcomes in type 2 diabetes (2021 · Medicine · 被引 20)
• An Aeromonas variant that produces aerolysin promotes susceptibility to ulcerative colitis (2025 · Science · 被引 18)